Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CNS Side Effects of Immune Checkpoint Inhibitors: Preclinical Models, Genetics and Multimodality Therapy
Gwendolyn J. McGinnis, Jacob Raber
Immunotherapy (2017) Vol. 9, Iss. 11, pp. 929-941
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Network (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 212
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Classical Examples of the Concept of the ASIA Syndrome
Vânia Vieira Borba, Анна Малкова, Natalia Basantsova, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1436-1436
Open Access | Times Cited: 88
Microglia in Cancer Therapy-Related Cognitive Impairment
Erin M. Gibson, Michelle Monje
Trends in Neurosciences (2021) Vol. 44, Iss. 6, pp. 441-451
Open Access | Times Cited: 75
Accumulation of cytotoxic T cells in the aged CNS leads to axon degeneration and contributes to cognitive and motor decline
Janos Groh, Konrad Knöpper, Panagiota Arampatzi, et al.
Nature Aging (2021) Vol. 1, Iss. 4, pp. 357-367
Closed Access | Times Cited: 73
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Emerging Role of PD-1 in the Central Nervous System and Brain Diseases
Junli Zhao, Alexus Roberts, Zilong Wang, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 8, pp. 1188-1202
Open Access | Times Cited: 56
Combined Effects of Three High-Energy Charged Particle Beams Important for Space Flight on Brain, Behavioral and Cognitive Endpoints in B6D2F1 Female and Male Mice
Jacob Raber, Joy Yamazaki, Eileen Ruth S. Torres, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 69
Novel Therapies for Glioblastoma
Elisa K. Liu, Erik P. Sulman, Patrick Y. Wen, et al.
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 7
Closed Access | Times Cited: 63
Targeting monoamine oxidase A for T cell–based cancer immunotherapy
Xi Wang, Bo Li, Kwang Gi Kim, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Closed Access | Times Cited: 51
Examining the Mechanisms behind Exercise’s Multifaceted Impacts on Body Composition, Cognition, and the Gut Microbiome in Cancer Survivors: Exploring the Links to Oxidative Stress and Inflammation
Benjamin Matei, Kerri M. Winters‐Stone, Jacob Raber
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 16
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators
Yifan Ma, H.S. Chen, Hui Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 7
New lung cancer treatments (immunotherapy and targeted therapies) and their associations with depression and other psychological side effects as compared to chemotherapy
Daniel C. McFarland
General Hospital Psychiatry (2019) Vol. 60, pp. 148-155
Open Access | Times Cited: 37
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
Anne Rogiers, Christophe Leys, Justine Lauwyck, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 28
Therapeutic strategies of recurrent glioblastoma and its molecular pathways ‘Lock up the beast’
Shaimaa M. El-khayat, Waleed Arafat
ecancermedicalscience (2021) Vol. 15
Open Access | Times Cited: 24
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, J. Belderbos, et al.
Radiotherapy and Oncology (2019) Vol. 133, pp. 163-166
Closed Access | Times Cited: 28
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak, et al.
Acta Oncologica (2020) Vol. 60, Iss. 1, pp. 69-77
Open Access | Times Cited: 23
Immune Checkpoint Inhibition-related Neuroinflammation Disrupts Cognitive Function
Onwodi V. Ifejeokwu, An Do, Sanad M. El-Khatib, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
Ketao Jin, Chunsen Mao, Lin Chen, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 229-229
Open Access | Times Cited: 17
Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis
Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review
Ekin Guran, Jian Hu, Jeffrey S. Wefel, et al.
British Journal of Anaesthesia (2022) Vol. 129, Iss. 6, pp. 909-922
Open Access | Times Cited: 7
Mice with pre-existing tumors are vulnerable to postoperative cognitive dysfunction
Tong Wu, Xiaoqiang Wang, Ruirui Zhang, et al.
Brain Research (2020) Vol. 1732, pp. 146650-146650
Closed Access | Times Cited: 10
Negative correlations of psychological distress with quality of life and immunotherapy efficacy in patients with advanced NSCLC.
Ziran Bi, Wen Li, Jie Zhao, et al.
PubMed (2022) Vol. 12, Iss. 2, pp. 805-815
Closed Access | Times Cited: 6
Das sogenannte "Chemobrain"
Georgia Schilling
Im Focus Onkologie (2023) Vol. 26, Iss. 4, pp. 52-57
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top